J. Mansour

FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines.

J. Achard, A. Fournier, J. Sérot, 2006, Journal of hypertension.

VALUE and supremacy of blood pressure control for cardiovascular protection.

J. Achard, A. Fournier, H. Mazouz, 2005, Journal of hypertension.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

The COOPERATE trial

G. Choukroun, A. Fournier, C. Presne, 2003, The Lancet.

Viewpoint: How Do Calcimimetics Fit Into the Management of Parathyroid Hormone, Calcium, and Phosphate Disturbances in Dialysis Patients?

G. Choukroun, A. Fournier, P. Morinière, 2005, Seminars in dialysis.

Is the angiotensin ii type 2 receptor cerebroprotective?

F. Messerli, J. Achard, A. Fournier, 2004, Current hypertension reports.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.

Z. Massy, G. Choukroun, A. Fournier, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study

Z. Massy, G. Choukroun, A. Fournier, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of angiotensin II type 1 receptor blockers in patients with self-monitored morning hypertension

G. Mansour, J. Mansour, 2008, Current hypertension reports.

[Diuretic-based therapy].

G. Choukroun, J. Achard, A. Fournier, 2007, Nephrologie & therapeutique.

Effect of combined treatment with candesartan and lisinopril in hypertensive patients with diabetes.

G. Mansour, J. Mansour, 2006, Current hypertension reports.